Browse Discover Builder Rankings Pricing

O

Ottimo

About

Developing first-in-class PD-1/VEGFR2 dual pathway antibodies for cancer

Private market intelligence for investors, founders, and sales teams.

Product

Browse
Discover
List Builder
Rankings
Pricing

Explore

Industries
Locations
Investors
Investor Types
Recent Funding
Funding Reports

Developers

API Reference
API Keys

Company

About
Terms
Privacy
Contact

© 2026 Indexed.vc. All rights reserved.